{"id":"https://openalex.org/W4388076606","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","title":"104 A spatial pharmacology approach to decipher drug-target-microenvironment interactions in situ","display_name":"104 A spatial pharmacology approach to decipher drug-target-microenvironment interactions in situ","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388076606","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0104"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0104","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057729645","display_name":"Guolan Lu","orcid":"https://orcid.org/0000-0002-5023-3465","observed_orcids":["https://orcid.org/0000-0002-5023-3465"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guolan Lu","raw_affiliation_strings":["Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033995613","display_name":"Garry P. Nolan","orcid":"https://orcid.org/0000-0002-8862-9043","observed_orcids":["https://orcid.org/0000-0002-8862-9043"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garry Nolan","raw_affiliation_strings":["Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086275218","display_name":"Eben Lloyd Rosenthal","orcid":"https://orcid.org/0000-0003-0294-5203","observed_orcids":["https://orcid.org/0000-0003-0294-5203"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eben Rosenthal","raw_affiliation_strings":["Vanderbilt University, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A118","last_page":"A118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7860999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7860999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11289","display_name":"Single-cell and spatial transcriptomics","score":0.14159999787807465,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9330000281333923},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.7889999747276306},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/drug-target-engagement","display_name":"drug-target engagement","score":0.6389999985694885},{"id":"https://openalex.org/keywords/spatial-transcriptomics","display_name":"spatial transcriptomics","score":0.8029999732971191},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9350000023841858},{"id":"https://openalex.org/keywords/immune-profiling","display_name":"immune profiling","score":0.5080000162124634},{"id":"https://openalex.org/keywords/in-vivo-drug-delivery","display_name":"in vivo drug delivery","score":0.6380000114440918},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6259999871253967},{"id":"https://openalex.org/keywords/immuno-oncology-biomarkers","display_name":"immuno-oncology biomarkers","score":0.796999990940094},{"id":"https://openalex.org/keywords/first-in-human","display_name":"first-in-human","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5959096550941467},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5021514892578125},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48184502124786377},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.468887060880661},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4478066861629486},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4466809332370758},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.4400920569896698},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4254269003868103},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36439183354377747},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36235618591308594},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3592073917388916},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3467786908149719},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32125741243362427},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2675537168979645},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2675310969352722},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20735293626785278},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10832521319389343},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0104","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:516fb7266c1640f294e978bf34c576c1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/516fb7266c1640f294e978bf34c576c1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0104","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0104","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7163382970","https://openalex.org/W7163864195","https://openalex.org/W7172515445","https://openalex.org/W7155186515","https://openalex.org/W7202254797","https://openalex.org/W3109885192","https://openalex.org/W4362595345","https://openalex.org/W4391983099","https://openalex.org/W2090216353","https://openalex.org/W3215635808"],"abstract_inverted_index":{"Background":[0],"Antibody-therapeutics,":[1],"including":[2],"immune-checkpoint":[3],"inhibitors,":[4],"have":[5,267],"transformed":[6],"cancer":[7,484],"patients\u2019":[8],"lives.":[9],"Despite":[10],"these":[11],"advances,":[12],"nearly":[13],"90%":[14],"of":[15,28,37,79,104,125,148,171,180,201,213,308,347,351,432,504],"oncology":[16],"drugs":[17,64],"fail":[18],"in":[19,42,51,74,161,163,221,226,235,240,277],"phase":[20,488],"III":[21],"clinical":[22,116,256],"trials":[23,117],"due":[24],"to":[25,94,252,275,291,304],"a":[26,89,126,134,206,269,283,487],"lack":[27,36],"therapeutic":[29,63,172,207,261],"efficacy.":[30],"One":[31],"major":[32],"challenge":[33],"is":[34,282,330],"the":[35,52,75,105,110,195,199,211,241,247,321,333,343,348,513],"technologies":[38],"that":[39,205,286],"can":[40,287],"measure":[41],"vivo":[43,278],"drug":[44,97,306],"delivery":[45,254],"and":[46,70,99,101,132,154,182,184,210,216,245,249,313,323,337,341,398,508],"activity":[47],"at":[48,109,223,237],"cellular":[49,100,248],"resolution":[50,225,239],"intact":[53,106,242],"human":[54,80,107,149,227,243,436],"tumor":[55,164],"microenvironment":[56],"(TME).":[57],"Thus,":[58],"it":[59],"remains":[60],"unclear":[61],"how":[62],"interact":[65],"with":[66,139,438],"various":[67],"cell":[68,203],"types":[69,204],"extracellular":[71],"matrix":[72],"(ECM)":[73],"complex":[76],"TME":[77,108],"ecosystem":[78],"patients.":[81],"Methods":[82],"To":[83],"address":[84],"this":[85,230],"challenge,":[86],"we":[87,266],"developed":[88],"single-cell":[90,190,224,271],"spatial":[91,146,185,191,272],"pharmacology":[92,192,273],"apporach":[93],"image":[95],"drug,":[96],"target,":[98],"ECM":[102,155,250],"components":[103],"(sub)cellular":[111],"resolution.":[112],"We":[113,130,157],"conducted":[114],"first-in-human":[115],"across":[118],"multiple":[119],"solid":[120],"tumors":[121,220],"by":[122,167,332,342,512],"intravenous":[123],"infusion":[124],"near-infrared":[127],"fluorescent":[128],"antibody.1\u20133":[129],"conjugated":[131],"validated":[133],"DNA-barcoded":[135],"CODEX":[136,174],"antibody":[137,208,253,292,429],"panel":[138],"over":[140],"50":[141],"protein":[142],"markers":[143],"for":[144,175,194,317,320,440,482],"deep":[145],"profiling":[147],"immune":[150,296],"cells,":[151],"cancer-associated":[152],"fibroblasts,":[153],"proteins.":[156],"measured":[158,232],"drug-target-microenvironment":[159,233],"interactions":[160,234],"situ":[162,222,236],"surgical":[165],"specimens":[166],"integrating":[168],"high-resolution":[169],"imaging":[170,179],"antibodies,":[173],"highly":[176],"multiplexed":[177],"proteomics":[178],"cells":[181],"ECM,":[183],"transcriptomics.":[186],"Results":[187],"The":[188,502],"integrative":[189],"technique,":[193],"first":[196],"time,":[197],"enabled":[198],"identification":[200],"specific":[202],"binds,":[209],"quantification":[212],"antibody-target":[214],"engagement":[215],"penetration":[217,431],"depth":[218],"into":[219,255,395,435],"tumors.":[228],"Furthermore,":[229],"method":[231],"unprecedented":[238],"TME,":[244],"identified":[246],"barriers":[251],"tumors,":[257],"which":[258],"has":[259],"important":[260],"implications.":[262],"Conclusions":[263],"In":[264],"summary,":[265],"established":[268],"novel":[270],"framework":[274,285],"decipher":[276],"drug-target-microenironment":[279],"interactions.":[280],"This":[281,299,328],"generalizable":[284],"be":[288],"broadly":[289],"applicable":[290],"therapeutics":[293],"such":[294],"as":[295],"checkpoint":[297],"inhibitors.":[298],"technique":[300],"holds":[301],"great":[302],"promise":[303],"uncover":[305],"mechanisms":[307],"action,":[309],"identify":[310],"optimal":[311],"doses,":[312],"seek":[314],"new":[315],"biomarkers":[316],"patient":[318,505],"stratification":[319],"current":[322],"next-generation":[324],"immuno-oncology":[325],"drugs.":[326],"Acknowledgements":[327],"work":[329],"funded":[331],"Stanford":[334],"Translational":[335],"Research":[336],"Applied":[338],"Medicine":[339],"grant":[340],"National":[344,349],"Cancer":[345,402],"Institute":[346],"Institutes":[350],"Health":[352],"under":[353],"Award":[354],"Number":[355],"K99CA267171.":[356],"References":[357],"Lu":[358,407,448],"G,":[359,408,449,470],"Fakurnejad":[360,417,463],"S,":[361,370,418,421,462,464],"Martin":[362,415,454],"BA,":[363,416,455],"van":[364,368,411,419,450,460],"den":[365,412,451],"Berg":[366,413,452],"NS,":[367,414,453],"Keulen":[369,420,461],"Nishio":[371,409,456],"N,":[372,384,410,457],"Zhu":[373],"AJ,":[374],"Chirita":[375,465],"SU,":[376,466],"Zhou":[377,471],"Q,":[378,472],"Gao":[379],"RW,":[380],"Kong":[381],"CS,":[382],"Fischbein":[383],"Penta":[385],"M,":[386],"Colevas":[387,422],"AD,":[388,423],"Rosenthal":[389,426,475],"EL.":[390,427],"\u2018Predicting":[391],"Therapeutic":[392],"Antibody":[393],"Delivery":[394],"Human":[396],"Head":[397],"Neck":[399],"Cancers\u2019.":[400],"Clin":[401],"Res.":[403],"2020":[404,445,498],"Jun":[405],"1;26(11):2582\u20132594.":[406],"Thurber":[424],"GM,":[425],"\u2018Co-administered":[428],"improves":[430],"antibody-dye":[433],"conjugate":[434],"cancers":[437],"implications":[439],"antibody-drug":[441],"conjugates\u2019.":[442],"Nat":[443],"Commun.":[444],"Nov":[446],"9;11(1):5667.":[447],"Hart":[458],"ZP,":[459],"Raymundo":[467],"RC,":[468],"Yi":[469],"Fisher":[473],"GA,":[474],"EL,":[476],"Poultsides":[477],"GA.":[478],"\u2018Tumour-specific":[479],"fluorescence-guided":[480],"surgery":[481],"pancreatic":[483],"using":[485],"panitumumab-IRDye800CW:":[486],"1":[489],"single-centre,":[490],"open-label,":[491],"single-arm,":[492],"dose-escalation":[493],"study\u2019.":[494],"Lancet":[495],"Gastroenterol":[496],"Hepatol.":[497],"Aug;5(8):753\u2013764.":[499],"Ethics":[500],"Approval":[501],"use":[503],"tissue":[506],"samples":[507],"data":[509],"was":[510,521],"approved":[511],"Stanford\u2019s":[514],"Institutional":[515],"Review":[516],"Board.":[517],"Written":[518],"informed":[519],"consent":[520],"obtained":[522],"from":[523],"all":[524],"patients":[525]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}